Strong H1 and Q2 results with robust sales and EBITDA growth, margin improvement, and solid cash generation. Outlook for 2026 is reaffirmed, with cost programs and innovation pipeline supporting future growth, while FX headwinds and restocking effects are closely monitored.Based on DSM-Firmenich AG…
Strong H1 and Q2 results with robust sales and EBITDA growth, margin improvement, and solid cash generation. Outlook for 2026 is reaffirmed, with cost programs and innovation pipeline supporting future growth, while FX headwinds and restocking effects are closely monitored.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.